(-)-Menthol inhibits WEHI-3 leukemia cells in vitro and in vivo

In Vivo

Volumn 21, Issue 2, 2007, Pages 285-289

  Lu, Hsu Fung ^a   Liu, Jia You ^a   Hsueh, Shu Ching ^a   Yang, Yi Yuan ^b   Yang, Jai Sing ^c   Tan, Tsu Wei ^c   Kok, Lai Fong ^d   Lu, Chi Cheng ^c   Lan, Sheng Huei ^c   Wu, Shan Ying ^c   Liao, Shiu Shin ^c   Ip, Siu Wan ^c   Chung, Jing Gung ^c  

^a CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

( ) Menthol; Apoptosis; BALB c mice; Cytotoxicity; WEHI 3 leukemia cells

Indexed keywords

CD11B ANTIGEN; CD19 ANTIGEN; MENTHOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CANCER INHIBITION; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME INHIBITION; GRANULOCYTE PRECURSOR; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; LIVER WEIGHT; MACROPHAGE; MOUSE; MURINE LEUKEMIA; NONHUMAN; SPLEEN WEIGHT; WEIGHT REDUCTION;

EID: 34047220360     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. MacDougall JM, Fandrick K, Zhang X, Serafin SV and Cashman JR: Inhibition of human liver microsomal (S)-nicotine oxidation by (-)-menthol and analogues. Chem Res Toxicol 16: 988-993, 2003.
2. Rudo K, Meyers WC, Dauterman W and Langenbach R: Comparison of human and rat hepatocytes metabolism and mutagenic activation of 2-acetylaminofluorene. Cancer Res 47: 5861-5867, 1987.
3. Russin WW, Hoesly JD, Elson CE, Tanner MA and Gould MN: Inhibition of rat mammary carcinogenesis by monoterpenoids. Carcinogenesis 10: 2161-2164, 1989.
4. Thorup I, Wurtzen G, Carstensen J and Olsen P: Short-term toxicity study in rats with pulegone and menthol. Toxicol Lett 19: 207-210, 1983.
5. Macht DI: Comparative pharmacology of menthol and its isomers. Arch Int Pharmacodyn 63: 43-58, 1939.
6. Gelal A, Jacob P, Yu L and Benowitz NL: Disposition kinetics and effects of menthol. Clin Pharmacol Ther 66: 128-135, 1999.
7. Opdyke DL: Monographs on fragrance raw materials. Food Cosmet Toxicol 14: 443-481, 1976.
8. Sidney S, Tekawa IS, Friedman GD, Sadler MC and Taskin DP: Mentholated cigarette use and lung cancer. Arch Intern Med 155: 727-732, 1995.
9. Ishidate M Jr, Sofuni T, Yoshikawa K, Hayashi M, Nohmi T and Sawada M: Primary mutagenicity screen of food additives currently used in Japan. Food Chem Toxicol 22: 623-636, 1984.
10. Ohta T, Watanabe M, Watanabe K, Shirasu Y and Kada T: Inhibitory effects of flavorings on mutagenesis induced by chemicals in bacteria. Food Chem Toxicol 24: 51-54, 1986.
11. MacDougall JM, Fandrick K, Zhang X, Serafin SV and Cashman JR: Inhibition of human liver microsomal (S)-nicotine oxidation by (-)-menthol and analogues. Chem Res Toxicol 16: 988-993, 2003.
12. Lin JP, Li YC, Lin WC, Hsieh CL and Chung JG: Effects of (-)-menthol on arylamine N-acetyltransferase activity in human liver tumor cells. Am J Chinese Med 29: 321-329, 2001.
13. JP Lin, Chen KC, Chen GW, Yang MD, Chiu TH and Chung JG: Effects of (-)-menthol on the distribution and metabolism of 2-aminofluorene in various tissues of Sprague-Dawley rats. In Vivo 7: 441-456, 2003.
14. Lin JP, Lu HF, Lee JH, Lin JG, Hsia TC, Wu LT and Chung JG: (-)-Menthol inhibits DNA topoisomerases I, II alpha and beta and promotes NF-kappaB expression in human gastric cancer SNU-5 cells. Anticancer Res 25: 2069-2074, 2005.
15. 2+ in (-)-menthol-induced human promyelocytic leukemia HL-60 cell death. In Vivo 20: 69-75, 2006.
16. Tang NY, Yang JS, Chang YH, Lu HF, Hsia TC, Lin WC and Chung JG: Effects of wogonin on the levels of cytokines and functions of leukocytes associated with NF-kappa B expression in Sprague-Dawley rats. In Vivo 20: 527-532, 2006.
17. Yu CS, Yu FS, Chuang YC, Lu HF, Lin SY, Chiu TH and Chung JG: Wogonin inhibits N-acetyltransferase activity and gene expression in human leukemia HL-60 cells. Anticancer Res 25: 127-32, 2005.
18. Yang JS, Kok LF, Lin YH, Kuo TC, Yang JL, Lin CC, Chen GW, Huang WW, Ho HC and Chung JG: Diallyl disulfide inhibits WEHI-3 leukemia cells in vivo. Anticancer Res 26: 219-225, 2006.
19. Ormerod MC: Flow Cytometry. Oxford University Press, pp. 61-82, 2000.
20. He Q and Na XD: The effects and mechanisms of a novel 2-aminosteroid on murine WEHI-3B leukemia cells in vitro and in vivo. Leukemia Res 25: 455-461, 2001.
21. Taghian AG and Suitt HD: Animal systems for translational research in radiation oncology. Acta Oncol 38: 829-838, 1999.
22. Zips A, Thames HD and Baumann M: New anticancer agents: in Vitro and in vivo eualuation. In Vivo 19: 1-8, 2005.
23. Gamba-Vitalo C, Blair OC, Keys SR and Sartorelui AC: Differentiation of WEHI-3B D+ monomyelocytic leukemia cells by retinoic acid aclacinomycin A. Cancer Res 46: 1189-1194, 1986.
24. Burgess AW and Metcalf D: Characterization of a serum factor stimulating the differentiation of myelomonocytic leukemia cells. Intl J Cancer 26: 647-654, 1980.
25. Metcalf D: Actions and interactions of G-CSF, LIF, and IL-6 on normal and leukemic murine cells. Leukemia 3: 349-354, 1989.
26. Li JM and Sartorelli AC: Synergistic induction of the differentiation of WEHI-3B D+ myelomonocytic leukemia cells by retinoic acid and granulocyte colony-stimulating factor. Leukemia Res 16: 571-576, 1992.
27. 3 receptor in the synergistic differentiation of WEHI-3B leukemia cells by vitamin D3 and retinoic acid. Exp Cell Res 249: 279-290, 1999.